Random triples
| Subject | Object |
|---|---|
| gptkb:D07451 | gptkb:DrugBank |
| gptkb:Crossref_Funder_ID:_501100011878 | gptkb:National_Natural_Science_Foundation_of_China |
| gptkb:R-HSA-264876.4 | gptkb:Reactome_pathway |
| gptkb:D06013 | gptkb:DrugBank |
| gptkb:R-HSA-264876.5 | CREB phosphorylation through the activation of CaMKII |
| gptkb:D01977 | Hyperandrogenism |
| gptkb:D00544 | gptkb:DrugBank |
| gptkb:C6833 | Clinical trial |
| gptkb:D011470 | Psoriasis |
| gptkb:P21912 | gptkb:Dopamine_receptor_D2_protein_in_Homo_sapiens |
| gptkb:D00744 | Meclizine |
| gptkb:R-HSA-1237044 | gptkb:Reactome_pathway |
| gptkb:R-HSA-264876.2 | gptkb:Reactome_pathway |
| gptkb:P33261 | gptkb:GLUT4 |
| gptkb:D006701 | Histocompatibility Antigens, Class I |
| gptkb:R-HSA-264876.7 | gptkb:Reactome_pathway |
| gptkb:R-HSA-264876.8 | CREB phosphorylation through the activation of CaMKII |